Close Menu

NEW YORK (GenomeWeb News) – Danaher today said that Steven Rales, its chairman of the board, will sell 15 million shares of Danaher common stock under SEC Rule 144.

The rule governs the public resale of restricted and control securities.

Danaher said that Rales is selling the shares in connection with his personal financial and estate planning. Following the sale, he will continue to hold more than 43 million shares of Danaher's outstanding common stock. Danaher has around 692.7 million total shares outstanding.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.